r e s o u r c e Whereas prokaryotes and archaea use a single RNA polymerase to transcribe their genomes, this function is divided in eukaryotes between several specialized enzymes 1 . The largest of these is Pol III, which has 17 subunits, all of which are required for cell viability. Pol III is responsible for ~10% of all nuclear transcription and makes short noncoding RNAs, including tRNA and 5S rRNA 1 . Other essential Pol III transcripts include 7SL RNA, which participates in protein trafficking, and U6, RNase P and MRP RNAs, which are required for processing mRNA, tRNA and rRNA, respectively 1 . MRP RNA also interacts with the catalytic subunit of telomerase reverse transcriptase 2 . In addition, Pol III synthesizes 7SK RNA, which controls the Pol II transcription elongation factor PTEF-b 3,4 , and HVG RNA, which forms part of the vault particles implicated in multidrug resistance 5 . Some studies also suggest that Pol III may be involved in transcription of miRNA genes 6,7 .
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Chromatin has been shown to exert a powerful influence on transcription by Pols I and II 8, 9 . Most attention has focused on the Pol II system, particularly in documenting the global chromatin modification patterns associated with protein-coding genes [10] [11] [12] . This study aims to broaden our understanding to include the chromatin status of Pol III templates in human cells. Our data reveal on a genome-wide scale that certain features of chromatin are shared between genes transcribed by Pols II and III; important distinctions are also observed between these two gene classes.
RESULTS

Epigenetic marks at human Pol III-transcribed genes
We analyzed histone modifications in human CD4 + T cells in the vicinity of Pol III-transcribed genes. We detected epigenetic marks usually associated with active Pol II transcription at many but not all Pol III genes. For example, comparison of two tRNA Leu TAA loci on chromosome 6 revealed strong mono-, di-or trimethylation at histone H3 Lys4 (H3K4me1/2/3) at one locus but not the other, whereas we observed the converse pattern for H3K27me3 ( Fig. 1) . To test if chromatin environment correlates with expression status of Pol III genes, we characterized their expression in CD4 + T cells using two approaches: high-throughput sequencing of cDNAs produced from total RNA (total RNA-seq) and chromatin immunoprecipitationsequencing (ChIP-seq) analysis of Pol III binding ( Supplementary  Table 1 ). A difficulty here is that RNA-seq reads derived from repetitive templates (like many Pol III genes) are frequently unmappable in a unique manner. However, these genes are often flanked by unique sequences, which allows mapping of Pol III occupancy as an indicator of gene activity. Although polymerase binding to a gene does not necessarily mean it is transcribed 10, 13, 14 , confidence can be gained from a strong correlation between the number of RNA-seq tags mapped to tRNA genes located in nonrepetitive loci and the number of Pol III ChIP-seq tags mapped in the vicinity (Spearman correlation R 2 = 0.796, P < 2.2 × 10 −16 ).
RNA-seq of total RNAs detected transcripts from the tRNA Leu TAA gene marked by H3K4me1/2/3 but not from the gene marked by H3K27me3 ( Fig. 1a,b) . Consistent with this, Pol III was cross-linked to the former but not to the latter. This suggests that H3K4 methylations correlate with tRNA expression, whereas H3K27me3 correlates with repression, as is well documented for Pol II transcription 10, 15, 16 .
To confirm this on a global level, we assessed 302 tRNA genes located in nonrepetitive areas of the genome and found that Pol III signals indeed correlate with H3K4me1/2/3 or H3K4 acetylation ( Fig. 2a , left, and Supplementary Fig. 1 ). For comparison, we also plotted the chromatin features for Pol II genes occupied or not occupied by polymerase ( Fig. 2 , right panels). Other histone methylation and acetylation signatures also correlate with activity of tRNA genes, including H3K9ac, H3K23ac, H3K27ac, H3K36ac and others. In addition, active tRNA genes are enriched in H2A.Z and various histone acetylations.
r e s o u r c e
In contrast, levels of H3K27me2/3 and H3K9me3 are higher at the inactive tRNA genes ( Fig. 2d , left, and Supplementary Fig. 1 ).
Although these features are similar to those of Pol II templates, some distinctions are also evident when the tag-density profiles are compared ( Fig. 2 and Supplementary Fig. 1) . A striking difference is that Pol III templates lack enrichment for H3K79me2 and H3K36me3 ( Fig. 2e-f ), which are deposited within Pol IItranscribed regions. In yeast, targeting of H3K36me3 is achieved by binding of Set2 methyltransferases to the phosphorylated C-terminal domain tail of elongating Pol II 17 , a structure that is absent from Pol III. Furthermore, several modifications, including H2AK9ac, H3K18ac, H3K27me1, H4K16ac and H4K20me1, are generally stronger at active than inactive tRNA genes but do not show the clear peaks found at transcription start sites (TSSs) of active Pol II genes ( Supplementary Fig. 1 ), suggesting that, although expressed genes are located in a permissive chromatin environment, these modifications are not targeted to Pol III genes specifically. H3K4me1/2/3/ac, H3K9ac, H3K18ac and H2A.Z are found in nucleosomes located on both sides of a Pol II TSS, especially the +1 nucleosome, whereas such modifications are strongest at the −1 nucleosome of tRNA genes and weaker after the TSS ( Fig. 2a-c) . It is likely that the weaker histone-modification signal at the +1 nucleosome of tRNA genes is caused by nucleosome loss. Indeed, histone H3 ChIP-seq experiments indicated enrichment of nucleosomes outside tRNA genes and a dramatic loss of histones within the tRNA genes bound by Pol III compared to those not bound by Pol III (Fig. 2g ). However, we also observed some histone depletion at inactive tRNA genes, which may be explained by reduced mappability of ChIP-seq reads at these sites. Alternatively, the continued presence of TFIIIC when transcription is low 18, 19 may exclude nucleosomes from tRNA-coding regions.
We also observed the chromatin features described above for tRNA genes at a variety of other Pol III templates, including genes encoding U6 snRNA, 7SK, 7SL, hY1-5, HVG1-3, RNase P and MRP RNAs ( Fig. 1c-f and data not shown). Among the 49 copies of U6 snRNA genes annotated in the human genome, we observed Pol III enrichment only at five loci (on chromosome 14, positions 31740801 and 31742026; on chromosome 15, position 65919237; on chromosome 19, positions 844283 and 972320). Also, we detected low levels of Pol III at chromosome 1 position 27524096. ChIP-seq was uninformative with regards to 5S rRNA genes because of their highly repetitive nature. Nevertheless, we conclude that a similar chromatin landscape is shared by a large proportion of disparate Pol III templates.
Cell-type specificity of Pol III gene expression
ChIP-seq analysis of Pol III in HeLa cells revealed similar patterns to CD4 + T cells. Although the majority of tRNA genes are used in both cell types, a surprisingly large number (26%) of them were associated with Pol III in only one of the cell types ( Fig. 3a) . This is consistent with a report that many tRNAs display tissue specificity 20 . An example is shown in Figure 3b , and it is noteworthy that H3K4me3 levels at this site are much higher in CD4 + T cells, where the gene appears active, than in HeLa cells, where Pol III binding is not detected. In contrast to the tRNA genes, we did not find differences between CD4 + T and HeLa cells in chromatin modifications or Pol III occupancy at U6 genes. r e s o u r c e Novel Pol III targets It has been suggested that Pol III is responsible for expression of C19MC, the largest miRNA gene cluster known in humans 6 . This, however, has been challenged 21 . We did not detect expression of these miRNAs or Pol III association in either CD4 + T or HeLa cells, which are different cell types from those used in the previous work. A possible exception is MIR498, where we detected a Pol III peak in CD4 + T but not HeLa cells (data not shown). However, this peak may be an artifact, as it did not coincide with Pol III transcription factors (TFIIIB and TFIIIC, data not shown) or the chromatin modifications detected at confirmed sites of Pol III transcription.
We also examined the miRNA loci that were reported to bind Pol III in melanoma and breast cancer cell lines 7 . However, only MIR565 showed Pol III binding in CD4 + T or HeLa cells (Supplementary Table 2 ), even though several of these miRNAs were expressed in CD4 + T cells 22 Table 2 ). The exception, MIR565, is actually a tRNA fragment, which explains the localization of Pol III there 23 . Our data therefore provide no evidence that miRNA loci are transcribed by Pol III in HeLa and CD4 + T cells.
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To identify novel loci that might be transcribed by Pol III, we identified Pol III binding sites in HeLa cells using only U0 tags and SISSRs software 24 and excluded sites that are located in the vicinity of known Pol III genes and Repeatmasker (http://www.repeatmasker.org) annotated repeats (detailed in Supplementary Table 3 ). Notably, we detected Pol III at 30 Pol II gene promoters, including MGC11102 ( Fig. 4a) . We also detected novel Pol III target sites either upstream of some Pol II target gene promoters or in intergenic regions free of any known gene units (Fig. 4b,c) . To assess further whether these are likely to be bona fide Pol III transcription units, we carried out genome-wide ChIPseq analyses for the Pol III-specific transcription factors TFIIIB and TFIIIC. TFIIIC is a DNA-binding factor that recognizes directly the promoters of most Pol III-transcribed genes; it then recruits TFIIIB, r e s o u r c e which in turn recruits Pol III and helps it to initiate transcription. The coexistence of TFIIIB and TFIIIC with Pol III in these regions (Fig. 4a-c) suggests that these sites have functional Pol III promoters. Consistent with this hypothesis, we detected transcripts by the total RNA-seq but not by polyA RNA-seq analyses (Fig. 4b,c) . Given that the polyA tail is a common feature of Pol II transcripts, these data suggest that Pol III might indeed transcribe these loci. Among the 177 novel sites bound by Pol III, 124 loci were also bound by both TFIIIB and TFIIIC, whereas 23 and 12, respectively, were bound by individual transcription factors ( Fig. 4d and Supplementary Table 3 ). We detected total RNA-seq signal at 42% of these loci. Analysis of the TFIIIB and TFIIIC ChIPseq data using similarly stringent parameters revealed 111 and 185 novel binding sites located away from known Pol III genes and repeats, respectively. Notably, the majority of these sites were also bound by Pol III and the other TFIII factor (Fig. 4e,f and Supplementary Table 3 ). These data suggest that, in addition to the known noncoding RNA genes, there is a large number of genomic regions that may be transcribed by Pol III in the human genome.
Pol II associates with Pol III-transcribed genes in human cells
A previous study 25 reported strong enrichment of Pol II in the region 300-700 bp upstream of the start sites of active U6 snRNA genes. Our Pol II ChIP-seq data confirmed this observation and revealed that the phenomenon is widespread. In addition to U6 snRNA genes, Pol II was found to be closely associated with a range of Pol III-transcribed genes, including 7SK, MRP, HVG and a large proportion of tRNA genes in human CD4 + T cells ( Figs. 1 and 5) . We excluded fortuitous cross-reaction by the use of four alternative Pol II antibodies (Fig. 5a) . Pol II was also present at tRNA promoters in other human and mouse cell lines, including ES, hematopoietic stem cells and B cells (data not shown) as well as in Drosophila S2 cells ( Fig. 5b) , suggesting that the recruitment of Pol II to Pol III-transcribed genes is evolutionarily conserved. We obtained similar results in HeLa cells by quantitative PCR-based ChIP assays ( Fig. 5c and Supplementary Fig. 2 ). This approach also allowed detection of Pol II at 5S rRNA genes (Fig. 5c) . We detected additional components of the Pol II transcription apparatus at Pol III templates, including TFIIB, TFIIE and TFIIH and the cyclin 
Figure 4
Novel Pol III binding sites. (a-c) Novel Pol III sites were found in the vicinity of known Pol II promoters (a,b) as well as in gene-free areas (c). The presence of total RNA-seq signal suggests that the binding of polymerase at these loci is productive. The absence of a corresponding polyA RNA-seq signal in b and c suggests that these loci are transcribed by Pol III rather than Pol II. (d-f) TFIIIB and TFIIIC can be found at the majority of the novel Pol III loci. r e s o u r c e T1 subunit of PTEF-b ( Fig. 5c and Supplementary Fig. 2) . Crosslinking to these sites shows specificity, as we did not detect it at the ApoE gene, which is not transcribed in these cells, or in a 'desert' region that lacks annotated gene sequences. In contrast, histone H3 could be cross-linked to each of the loci (Fig. 5c) . Additional evidence of specificity was provided by the Pol I factor TAF I 48, which we did not detect at any site analyzed (Fig. 5c) . Whereas the Pol III signal peaked at the tRNA-coding region, as expected, we typically found peaks of Pol II ~200 bp upstream of these genes ( Supplementary  Fig. 2) . This was especially clear in ChIP-seq tag-density profiles (Fig. 5d) . However, there was considerable overlap of Pol II and Pol III enrichment at these loci.
DISCUSSION
Histone modifications at Pol III-transcribed genes
This study provides a detailed global analysis of the modification status of histones associated with Pol III-transcribed genes. It shows a clear correlation between histone acetylation and apparent gene activity. A partial explanation is offered by evidence that tRNA and 5S or U6 genes are bound and induced by the GCN5 and p300 acetyltransferases 19, 26 . These data are consistent with previous evidence that expression of tRNA and 5S rRNA genes can be stimulated by acetylation of core histones both in vitro and in vivo 19, [26] [27] [28] [29] [30] [31] . In contrast, histone methylation had not previously been implicated as a major contributor to Pol III regulation. Our analysis reveals that genes that are bound and expressed by Pol III are marked by H3K4me1/2/3, whereas H3K9me3 and H3K27me2/3 correlate with apparent inactivity. Cause and effect are not distinguishable from these observations, so it will be important to test if the methylases responsible for these modifications are able to influence Pol III transcription.
What brings Pol II to Pol III-transcribed genes?
We cannot yet explain the unexpected presence of Pol II and its associated basal factors at Pol III-transcribed genes. We found strong correlation between the detection of Pols II and III at tRNA genes (Spearman R 2 = 0.768, P < 2.2 × 10 -16 ), suggesting that both polymerases are recruited to these sites by a common mechanism. Shared components of the transcriptional machinery might be involved. For example, TATA-binding protein can nucleate assembly of a Pol II preinitiation complex and is present at all Pol III-transcribed genes as part of TFIIIB 32 . Most Pol III templates also utilize c-myc 33 , which might recruit Pol II transcription factors just as it brings GCN5 to tRNA and 5S rRNA genes 19 . It is likely that much more overlap remains to be discovered between transcription factors that have been regarded as being specific for Pol II or Pol III. For example, the Pol II elongation factor TFIIS was recently found to stimulate Pol III occupancy and transcription of tRNA genes in yeast 34 . A complex balance of interactions and influences may determine the occupancy of each individual site, depending on conditions.
Significance of Pol II at Pol III-transcribed genes
It is unclear to what extent Pol II transcribes DNA at the Pol III loci. Pol II products derived from these sites have not been identified, but one cannot exclude transcripts that are too rare or short lived to be detected. An argument against this is the apparent absence of H3K36me3 and H3K79me2, which are generally found in Pol IItranscribed regions. However, we do detect Pol II with its C-terminal domain phosphorylated at Ser2 and Ser5, modifications that occur after RNA synthesis commences. We can also cross-link cyclin T1, a component of the Pol II elongation factor PTEF-b. Some level of Pol II transcription initiation may therefore occur at these apparently ectopic sites, even if it is unproductive.
Previous work 25 observed strong enrichment of Pol II in the region upstream of the start sites of active U6 snRNA genes. It was convincingly shown that low doses of α-amanitin reduced cross-linking of Pol II and acetylation of histone H4 at these sites and decreased Pol III-mediated synthesis of U6 snRNA 25 . On this basis, it was speculated that Pol II recruitment upstream of the U6 promoter might facilitate Pol III transcription by modifying the local chromatin structure 25 . Our evidence for Pol II slightly upstream of multiple Pol III-transcribed genes, along with peaks of positive histone modifications, supports the idea that Pol II might attract histone-modifying enzymes to these loci. However, in contrast to U6 snRNA, the previous study 25 saw little or no effect on expression of other Pol III transcripts when Pol II was selectively inhibited with α-amanitin. These prior observations suggest that Pol III activity at a subset of loci may be affected by Pol II, although indirect effects cannot be excluded. Our own experiments with short-term α-amanitin treatment (using a higher concentration than that used in the previous study 25 ) are also consistent with Pol II activity being able to influence expression of some Pol III products (Fig. 6) . However, these data must be treated with great caution, as direct and indirect effects are very difficult to distinguish in vivo.
Pol III-transcribed genes have been shown to act as boundary elements in both yeast and mammals 35, 36 . In yeast, tRNA genes can serve as barriers to the propagation of heterochromatin [37] [38] [39] [40] . This effect is dependent on the Pol III transcription apparatus and involves the establishment of a discontinuity in arrayed nucleosomes that can interfere with heterochromatin spreading. Histone acetylation is also involved 38 . The histone acetylation and strong nucleosome depletion we observe at the TSSs of active human tRNA genes might produce similar effects. Barrier function has also been ascribed to a B2 gene within the mouse Growth Hormone locus, which buffers against encroachment by facultative heterochromatin 35 . B2 is a Pol III-transcribed family of short interspersed elements (SINEs) that are derived from tRNA genes 41 . B2 SINEs can be bound by upstream stimulatory factor 42 , a factor shown to mediate barrier function 43 . Chromatinmodifying enzymes recruited by upstream stimulatory transcription factor promote H3K4 methylation and acetylation of histone H3, which were proposed to counteract the propagation of heterochromatin 43 . It is therefore noteworthy that we have found such marks to be a general feature of active Pol III-transcribed genes, suggesting that barrier activity may be a widespread property of such loci. Another boundary function is to insulate sites against the action of distal enhancers 35 . A Pol III-transcribed SINE belonging to the Alu family has been shown to display such insulator activity in transgenic mice 44 . The promoter decoy or mimicry model 45 posits that insulators recruit components of the transcription machinery that trap enhancers in unproductive interactions. This is strongly reminiscent of the frequent presence of Pol II and associated factors that we have discovered at Pol III-transcribed genes, perhaps reflecting insulator activity at these sites. Our data therefore raise the possibility that Pol III transcription units may play a much larger role than previously envisaged in organizing the human genome into discrete functional domains.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
Accession codes. The ChIP-seq and RNA-seq data have been deposited in the NCBI GEO database (GSE20072).
